Attached files
| file | filename |
|---|---|
| EX-10.3 - EXHIBIT 10.3 AMENDMENT TO NOTE 7.7.15 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | f10q063015_ex10z3.htm |
| EX-10.1 - EXHIBIT 10.1 PROMISSORY NOTE - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | f10q063015_ex10z1.htm |
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | f10q063015_ex31z1.htm |
| EX-10.5 - EXHIBIT 10.5 AMENDMENT TO NOTE 8.1.15 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | f10q063015_ex10z5.htm |
| EX-10.4 - EXHIBIT 10.4 AMENDMENT TO NOTE 8.1.15 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | f10q063015_ex10z4.htm |
| EX-10.2 - EXHIBIT 10.2 AMENDMENT TO NOTE 5.7.15 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | f10q063015_ex10z2.htm |
| 10-Q - FORM 10-Q QUARTERLY REPORT - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | f10q063015_10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Jolley Marketing, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2015, as filed with the Securities and Exchange Commission (the “Report”), the undersigned principal executive and financial officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 13, 2015
/s/ Steven L. White
Steven L. White, President
(Principal Executive Officer and Principal Financial Officer)